VERU (verupharma.com) Earnings per share growth rate in current year
Veru Inc. biotechnological capacities are operating strictly on schedule, ensuring timely equipment calibration and plant redundancy. Revenues are generated through the sale of women's health products and promising oncology drugs. The company focuses on prostate and breast cancer therapies, including the maintenance of muscle mass. The 12-month relative EPS growth rate reflects a trend where the value stands at 47.30.
Comprehensive metric breakdowns and analytics for verupharma.com (VERU)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and solvency information:
- earnings and valuation multiples information:
VERU - Net Profit|Future Profit Veru Inc.|VERU - Price to Earnings Ratio|Market Cap to Projected Earnings Veru|VERU - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veru|VERU - Operating profit EBITDA|Net earnings per one share for the last twelve months Veru|VERU - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months verupharma.com|VERU - Net earnings per share growth this year|Earnings growth forecast for next year Veru Inc.
- sales volume and revenue information:
Summary company analysis:Veru Pharma (VERU)
This indicator measures the annual growth of earnings per share, reflecting the rate of change in the business's net yield. Investors utilize this metric to assess capital resilience against market volatility and shocks. By analyzing the EPS YoY percentage shift, one can determine the efficiency of operational expense management. For Veru Inc. (VERU), such volatility is mitigated by the presence of patented oncology drugs. Stable sales of medical formulas ensure the predictability of this metric.
Direct competitors
Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma
